Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
This content was sponsored by Boston Scientific. EuroPCR is the premier global forum for advancing interventional cardiovascular medicine. At its 2025 edition, the Pulmonary Embolism (PE) Symposium ...
Acute pulmonary embolism (PE) remains a diagnostic and therapeutic challenge, with an estimated 60,000-100,000 deaths each year in the United States. 1 Although the management of high-risk PE ...
Background: Pharmacomechanical catheter-directed thrombolysis (PCDT) is commonly used to treat acute deep venous thrombosis (DVT). The AngioJet Rheolytic Thrombectomy (ART) device is a widely used ...
Objective: To compare the efficacy and safety outcomes between percutaneous mechanical thrombectomy (PMT) and catheter-directed thrombolysis (CDT) as the first endovascular revascularization (EVR) ...
The global catheter-directed thrombolysis market is experiencing robust growth, projected to reach USD 510.0 million by 2025 and climb further to an estimated USD 906.2 million by 2035. This expansion ...
1. In this cohort of patients with a pulmonary embolism (PE), ultrasound catheter-directed thrombolysis (USAT) is safe for symptomatic patients with intermediate-high and high-risk acute PE. Immediate ...
A current study involving the University Hospital Bonn (UKB) has investigated which treatment strategy offers the best chances of survival in high-risk acute pulmonary embolism. The results, now ...
WASHINGTON, DC — Large-bore mechanical thrombectomy is superior to catheter-directed thrombolysis for pulmonary embolism, according to a randomized trial comparing the two interventions. Although ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback